Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research
- PMID: 38418013
- DOI: 10.1016/j.jacc.2023.12.030
Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research
Comment on
-
Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.J Am Coll Cardiol. 2024 Mar 5;83(9):e87. doi: 10.1016/j.jacc.2023.09.838. J Am Coll Cardiol. 2024. PMID: 38418012 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
